FWD 2 Commission E: Kelp

  The Commission E Monographs

Kelp


Laminariae stipites
Laminariastiele
Published July 14, 1993

Name of Drug

Laminariae stipites, kelp.  

Composition of Drug

Kelp consists of the dried, stem-like parts of the thallus of Laminaria hyperborea (Gunn.) Foslie (syn.   L.  cloustonii (Edmondston) Lejolis) [Fam.  Lami-nariaceae], as well as preparations thereof.  

Pharmacological Properties, Pharmacokinetics, Toxicology

Not known.  

Clinical Data

Uses

Preparations of kelp are used for the regulation of thyroid function, as well as in combination for goiter.  

The effectiveness for the claimed applications is not verified.  

Risks

Preparations containing a maximum daily dosage of 150 µg of iodine:

None known.  

Above the dosage of 150 µg of iodine per day, there is danger that hyperthyroidism is induced or made worse.  In rare cases allergic reactions involving serious overall reactions may occur.  

Evaluation

Since the effectiveness for the claimed applications using a dosage below 150 µg iodine per day is not documented, a therapeutic administration cannot be recommended.  

Above a dosage of 150 µg iodine per day, a therapeutic application cannot be recommended, because the effectiveness is not verified and the risks cannot be justified.